News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

APP Pharmaceuticals Announces Increased Availability of APP Diprivan(R) and APP Propofol 1%


10/17/2011 9:19:37 AM

SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today increased availability of APP Diprivan® (propofol 1%) and APP Propofol 1% (authorized generic Diprivan®). Both are now readily available and APP has the supply necessary to meet the clinical needs of health care professionals.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES